Navigation Links
Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
Date:2/7/2008

MAUI, Hawaii, Feb. 7 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT) today announced that sales for the month of January 2008 increased 40% compared to sales for the month of January 2007.

"We achieved a record breaking month of sales in January, primarily from continued success of our Flight Spray product. We are also gaining market traction for our latest product release, an all-natural solution for baby care marketed under the Gentle Mother(TM) line," said Steven M. Schorr, Chairman & CEO of Bioponic. "Bioponic is now focused on establishing distribution relationships that will greatly expand the availability of multiple product lines, including O-Spray(TM), Throat Note(TM), Gentle Mother(TM), Hawaiian Healing Mist, and Noni Healing Tonic for placement into national health food stores and natural products retailers. Our goal is take our core product lines and position them for exponential sales growth, much like Flight Spray achieved when it gained a presence in over 1,000 points of distribution."

"We have secured an agreement with a leading wholesaler-distributor in the Natural Food industry to bring five of our all natural health and wellness product lines, representing 11 products, into 1,000 retail stores in the Western U.S. We expect the results of this distributorship, and other marketing channels, will lead to aggressive total revenue growth for Bioponic in 2008," said Schorr.

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics(TM)" and has several branded product lines currently in national distribution. For further information, please see http://www.bioponic.com.

All statements oth
'/>"/>

SOURCE Bioponic Phytoceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced ... at The American Society of Hematology 51st Annual Meeting ... presented on the clinical results from the Phase 1 ... pharmacokinetic/pharmacodynamic (PK/PD) profile in dose levels ranging from 100 ...
(Date:12/2/2009)... China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" ... a leading pharmaceutical company,specializing in the development, manufacturing, ... China, today announced that 105 of,its drugs have ... which was issued by China,s Ministry of Human ...
(Date:12/2/2009)... -- The world is going through,extraordinary times; markets are ... industries. It turns out that the pharma industry has ... take a,vacation. , During the ... Johnson & Johnson inaugurated an R&D center in Shanghai, ...
(Date:12/2/2009)... to the National Institute of Health, 40 percent to 45 ... of diabetic retinopathy. Diabetic retinopathy, damage to the retina ... blindness in people with diabetes and is one of the ... percent of all patients who,ve had diabetes for 10 years ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
... Support R&D Efforts and Clinical Trials Advancing,the BiTE ... Micromet, Inc.,(Nasdaq: MITI ) ("Micromet" or ... for the treatment of cancer,inflammation and autoimmune diseases, ... agreement with various institutional investors to raise,$40 million ...
... 19 - 22,2008, the fairgrounds in Dusseldorf, Germany ... - World Forum for Medicine. As the,leading international ... will,feature about 4,300 exhibitors, two major congresses, an ... at MEDICA 2008 will include the latest products ...
... BOSTON, Sept. 30 Solos Endoscopy, Inc. (Pink,Sheets: ... intends to expand,their current industry to include and ... by implementing a business,strategy. The Company,s strategy is ... its customer base., Solos Endoscopy expects continuous ...
Other Biology Technology:Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 2Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 3Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 4MEDICA 2008 Returns in November 2Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market 2
(Date:12/3/2009)... 3, 2009) Van Andel Research Institute (VARI) ... (ABA) works at the molecular level to help plants respond ... findings, published in the journal Nature , could help ... and combat global food shortages. The findings could also ...
(Date:12/3/2009)... the past three years in the troposphere (lower atmosphere) ... results, which are the first of their kind in ... between 2002 and 2005. , Over recent years, physicists ... carbon dioxide (CO2) levels, and how these have evolved ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 1Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 3Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 4Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 1Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 2Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 3Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 4Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 6Mixed Marks for Swine Flu Updates 50875 1Mixed Marks for Swine Flu Updates 50875 2
... DALLAS July 6, 2008 Tiny strands of genetic material ... as major players in gene regulation, the process inside cells that ... to fight disease. , The idea that RNA (ribonucleic acid) ... it has been unclear how RNA strands might regulate the process. ...
... Diversity among the ancestors of such marine creatures as ... rise beginning 144 million years ago with no clear ... This contradicts previous work showing dramatic increases beginning 248 ... diversity., "Some of the time periods in the past ...
... Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKline company ... treat diseases of aging such as Type 2 Diabetes, ... today,s online edition of Cell Metabolism that ... showed an overall health improvement, including improved bone health, ...
Other Biology News:UT Southwestern researchers identify new targets for RNAs that regulate genes 2UT Southwestern researchers identify new targets for RNAs that regulate genes 3Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3
...
... autofluorescent pigment lipofuscin accumulates in the ... neurons. The presence of lipofuscin granules ... microscopy in the central nervous system ... emission spectra, which overlaps with those ...
Purified anti-LAT...
Polyclonal Antibody to AHI1 / Jouberin...
Biology Products: